Trial intelligence / Profile preview

Paliperidone Palmitate in Bipolar Disorder with Alcoholism

NCT01211704Phase 4Withdrawn

Sponsor
University of Miami
Start
Oct 2010
Primary completion
Dec 2011
Modality
Metabolically Activated Prodrugs
01

Overview

A Phase 4 trial of paliperidone palmitate in bipolar I disorder, sponsored by University of Miami. Planned start Oct 2010; status: withdrawn.

02

Drugs

paliperidone palmitate
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT01211704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01211704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call